Page last updated: 2024-08-21

maleimide and Kidney Neoplasms

maleimide has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anraku, T; Bilim, V; Giles, FJ; Kazama, A; Kuroki, H; Mazar, A; Schmitt, D; Tasaki, M; Tomita, Y; Ugolkov, A	1

Other Studies

1 other study(ies) available for maleimide and Kidney Neoplasms

Article	Year
Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer. International journal of molecular medicine, 2020, Volume: 45, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Glycogen Synthase Kinase 3 beta; Humans; Kidney Neoplasms; Maleimides; Protein Kinase Inhibitors	2020

Article

Year

Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.

International journal of molecular medicine, 2020, Volume: 45, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Glycogen Synthase Kinase 3 beta; Humans; Kidney Neoplasms; Maleimides; Protein Kinase Inhibitors

2020